Berlaymont, European Commission’s Headquarter in BrusselsThe European Commission’s Bioeconomy Knowledge Centre (BKC) will be launched tomorrow in Brussels as the Commission’s central knowledge hub on the bioeconomy.
Christophe Schilling, CEO of Genomatica during his speech at the Grand Opening of Mater Biotech’s plant in Bottrighe di Adria, Italy
Genomatica has strong results for its GENO BDO biobased process technology regarding overall process performance and production volume to date for bio-based 1,4-butanediol (BDO). Novamont, Genomatica’s first GENO BDO licensee, has officially confirmed that its new industrial plant in Bottrighe, Italy has met all performance guarantees committed to by Genomatica. The guarantees include technical and economic parameters, such as efficiency of converting feedstock sugars to Bio- BDO product and product quality. The process runs as designed, as modeled, and as represented.
Arkema will invest some 300 million euros over five years in the biosourced polyamide 11 chain. This major investment will enable the French chemical group to increase by 50% its polyamide 11 global production capacities. The project falls in line with Arkema’s strategy to speed up its development in advanced materials, one of the key pillars of its future growth, sustained by a unique portfolio of innovations around the main sustainable development trends.
There is a new partnership in the world bioeconomy. Indian Oil Corporation Limited, India’s flagship national oil company and, LanzaTech, carbon recycling company based in Illinois, signed a Statement of Intent to construct the world’s first refinery off gas-to-bioethanol production facility in India.
Italian oil giant Eni, the City of Turin, GTT (Gruppo Torinese Trasporti) and Amiat, an Iren Group company, have signed an agreement to launch a large-scale experimental project with Turin buses using Eni Diesel+, the new Eni fuel with a 15% of renewable component. Under the agreement, the Turin public transport company will pay Eni Diesel+ at the same price as the diesel fuel that its vehicles have used on the urban network up to now. This follows Eni’s success at the tender to supply the fuel for Turin’s buses.
Aerial view of Kalundborg sustainable industry complex
Novozymes, Novo Nordisk, Kalundborg Forsyning and DONG Energy signed a new 20-year agreement which enables Denmark’s largest coal-fired power station unit, the Asnæs Power Station, to phase out coal and replace it with wood chips. Novozymes sources steam from the power station.
“The UK cannot solve the problem on its own, and we will need to collaborate with foreign governments and companies if we are to truly tackle the crisis ahead.” To say it referring to Brexit – in this exclusive interview with Il Bioeconomista – is Jaymin Amin, COO at Ingenza, the spin-out from the University of Edinburgh founded in 2002, which is today one of the most dynamic European industrial biotech company. With Amin we talk about industrial biotechnology and bioeconomy in Scotland.
The Metsä Group’s bioproduct mill start-up will begin in mid-August, and pulp deliveries from the new mill to customers will begin in early September. The current pulp mill at Äänekoski – the company announced – will be shut down once the bioproduct mill starts up.
Queensland Premier Annastacia PalaszczukAmyris, the U.S. industrial bioscience company, and the Government of Queensland, Australia, announced the next step their plans to develop a leading industrial biotechnology hub in Southeast Asia. Plans call for developing a new production plant with support from local partners to produce Amyris’s sugar cane-based ingredient called farnesene, which is used in products including cosmetic emollients, fragrances, nutraceuticals, polymers, and lubricants.
ExxonMobil, the largest publicly traded petroleum and petrochemical enterprise in the world, and Synthetic Genomics Inc., a global leader in the fields of synthetic biology and synthetic genomics, achieved a breakthrough in joint research into advanced biofuels involving the modification of an algae strain that more than doubled its oil content without significantly inhibiting the strain’s growth.
Arkema will invest some 300 million euros over five years in the biosourced polyamide 11 chain. This major investment will enable the French chemical group to increase by 50% its polyamide 11 global production capacities. The project falls in line with Arkema’s strategy to speed up its development in advanced materials, one of the key pillars of its future growth, sustained by a unique portfolio of innovations around the main sustainable development trends.
ExxonMobil, the largest publicly traded petroleum and petrochemical enterprise in the world, and Synthetic Genomics Inc., a global leader in the fields of synthetic biology and synthetic genomics, achieved a breakthrough in joint research into advanced biofuels involving the modification of an algae strain that more than doubled its oil content without significantly inhibiting the strain’s growth.
IL BIOECONOMISTA 